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might create distinct environments in each compart-
ment where particular motors, or motor-bound regula-
tory proteins, are activated or deactivated. In this way,
motors would gain access to a compartment only if
the appropriate activators were present (or deactivators
absent).
Both in vitro biophysical characterizations and in vivo
molecular genetic approaches will be required to deter-
mine which of the structural, activation, and other possi-
ble ªintelligenceº hypotheses are essential in protein
sorting.
In any case, the work of Burack and colleagues paves
the way for further study of the role of the motor proteins
themselves in neuronal protein sorting and the elucida-
tion of specific protein trafficking mechanisms for other
proteins. With this dynamic, manipulable system in
hand, the role of primary sequence determinants, MT
motor identities, and specific posttransport mecha-
nisms of sorting can now be attacked.
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ªSmartº versus ªDumbº Motor Transport
Selected ReadingCurrent evidence suggests that protein sorting in neurons may take
place through one of two mechanisms.
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What makes a smart motor smart and what cues does
a smart motor use to direct its motion to one specific
compartment of the cell? In neurons, the smart motors
might use differences in MT structure in the dendrite Orphanin FQ/Nociceptin
versus axon to preferentially access one compartment. and the Mystery of PainSuch differences in MT structure could be accomplished
through posttranslational modifications of tubulin, use
of specific tubulin isoforms, or microtubule-associated
proteins that are differentially localized to axons versus Opioids have long been known for their pain-relieving
and euphoric properties and have played a central roledendrites. For example, MAP2 and hypophosphorylated
tau are well-known markers for dendrites and axons, in the elucidation of pain circuits in the brain and spinal
cord. A major breakthrough in opioid research came inrespectively. Alternatively, the polarity of the neuron
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Mogil et al. (1996) demonstrated that OFQ/N-induced
hyperalgesia was dependent on the state of the animal.
Intracerebroventricular injection of saline in mice caused
stress-induced analgesia that was mediated by endoge-
nous opioids and was reversed by OFQ/N. Surprisingly,
OFQ/N did not produce any hyperalgesia relative to un-
injected animals in this paradigm. The authors reasoned
that in previous studies where OFQ/N was applied by
i.c.v. injection, OFQ/N was not hyperalgesic by itself
but rather reversed stress-induced analgesia caused by
endogenous opioids. Indeed, as a subsequent study
showed, when OFQ/N was supplied through a preplaced
cannula, rather than via a relatively ªstressfulº i.c.v. in-
jection, OFQ/N had no effect in pain assays when admin-
istered alone but inhibited morphine-induced analgesia
(Tian et al., 1997). Hence, OFQ/N was not hyperalgesic
but was rather acting as an anti-opioid.
Despite the rapid pace of discovery in this new field,
unsolved mysteries remained concerning the role of
OFQ/N in modulating pain. One critical question is: how
OFQ/N Can Inhibit Both Primary and Secondary Neurons in the can OFQ/N produce an anti-opioid effect on pain modu-
Nucleus Raphe Magnus
lation when its cellular effects are similar to that of opi-
(Top) During acute opioid treatment, m opioid receptors on second- oids? This issue was addressed in a paper in which
ary cells inhibit cell firing, and indirectly disinhibit primary cells.
behavioral and electrophysiological techniques wereIncreased activity of the primary cells produces analgesia, an effect
combined (Heinricher et al., 1997). This study demon-which is blocked via OFQ/N inhibition of primary cells.
strated that coinjection of OFQ/N with an opioid into the(Bottom) During naloxone-precipitated withdrawal from chronic opi-
oid treatment, secondary cells depolarize, producing hyperalgesia. rostral ventromedial medulla inhibited opioid-induced
OFQ/N hyperpolarizes both cell types, blocking hyperalgesia and analgesia. Opioids had previously been shown to pro-
restoring normal pain sensitivity. duce analgesia by increasing the activity of one type
of neuron in this area of the brainstem, the ªoff cell.º
OFQ/N inhibited the firing rate of this cell type, function-1992 with the cloning of the d opioid receptor. This led
ally countering the effects of opioids. This result pro-to homology cloning of the other major opioid receptors:
vided the first description of the mechanism by which
m and k. Further attempts to isolate subtypes of opioid
OFQ/N blocks opioid analgesia. However, several ques-receptors led to the cloning of an orphan receptor with
tions remain unanswered. What is the exact cellular mech-a high (z65%) homology to the three identified opioid
anism by which OFQ/N inhibits the off cells? Is this a
receptors but with a very low affinity for known opioid
direct effect on these ªoffº neurons, or does OFQ/N act
receptor ligands. This was the beginning of a series of
indirectly by affecting neighboring cells, suggesting a
mysteries that have had profound implications for the
more complex circuit effect? Can the cellular actions of
study and management of pain (reviewed by Henderson OFQ/N predict differential effects on pain modulation
and McKnight, 1997; Meunier, 1997; Darland and Grandy, depending on the state of the animal? These questions
1998; Darland et al., 1998). have now been addressed in the article by Pan et al.
The first and most important mystery that needed to (2000) in this issue of Neuron.
be solved was the identity of the endogenous ligand for Pan et al. (2000) also combined electrophysiological
the new orphan receptor. This was soon accomplished and behavioral assays, this time using an in vitro slice
with the identification of a heptadecapeptide isolated preparation and whole-cell recording to determine the
from rat (Meunier et al., 1995) and pig (Reinscheid et cellular actions of OFQ/N in the nucleus raphe magnus
al., 1995) brain and called nociceptin and orphanin FQ, (NRM) region of the brainstem. This region directly regu-
respectively. Both studies demonstrated that the newly lates pain transmission in the spinal cord and plays a
discovered peptide bound to the orphan opioid receptor critical role in mediating opioid analgesia. This paper
with high affinity and coupled to the inhibition of adenylyl builds on previous work which demonstrated that pain
cyclase. Subsequent biochemical and physiological ex- responses can be differentially modulated by the activity
periments showed that the new peptide activated potas- of two functionally opposing neurons in the NRM: pri-
sium currents and inhibited calcium currents in a manner mary and secondary cells (Pan et al., 1997; Fields, 2000).
similar to traditional opioids. Behavioral experiments, m opioid receptors produced analgesia by directly inhib-
however, immediately revealed a new mystery. When iting secondary cells, which in turn indirectly activated
injected intracerebroventricularly (i.c.v.), Orphanin FQ/ primary cells. In contrast, k opioid receptors can reverse
Nociceptin (OFQ/N) produced hyperalgesia, rather than m receptor±mediated analgesia by directly inhibiting pri-
analgesia, in behavioral assays (Meunier et al., 1995; mary cells (Pan et al., 1997). Hence, m and k receptors
Reinscheid et al., 1995). This pain-enhancing, rather produced opposite effects on pain modulation because
than pain-relieving, property was quite unexpected for they inhibited two functionally opposing cell types in the
an opioid peptide and generated considerable interest in NRM. In the present paper, Pan et al. (2000) demonstrate
determining the mechanism of this hyperalgesic effect. that a similar mechanism can account for the anti-opioid
effects of OFQ/N. They first demonstrate that OFQ/NThe next breakthrough came only a year later, when
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hyperpolarized both primary and secondary neurons transduction mechanisms at work in addition to the acti-
vation of potassium currents. It is possible that m recep-through the activation of an inwardly rectifying potas-
sium current. Furthermore, OFQ/N occluded further inhi- tors disinhibit primary cells through a decrease in GABA
release from terminals, as well as through a direct inhibi-bition by m and k agonists, suggesting that the orphan
opioid receptor is coupled to the same potassium chan- tion of secondary cell bodies. Is the inhibition of primary
and secondary cell firing enough to block opioid effects,nels as m and k receptors. The authors went on to show,
using a tail-flick assay to measure pain responses, that even if there are additional opioid effects on nerve termi-
nals? Is it possible that orphan opioid receptors aremicroinjection of OFQ/N directly into the NRM counter-
acted the analgesic effect of m receptor agonists, sug- located on nerve terminals as well, and modulate neuro-
transmitter release in addition to modulating membranegesting that the inhibitory effects of OFQ/N on primary
and secondary neurons had a net anti-opioid effect on potential? Do m receptors disinhibit primary cells only by
inhibiting secondary cells, or are m receptors located onanalgesia.
other synaptic inputs to the primary cells? Can OFQ/NThese results provide a cellular correlate to the behav-
counter these effects as well? While the model proposedioral data showing that OFQ/N opposed opioid-medi-
by Pan et al. is central to understanding pain sensitivity,ated analgesia. Taking this result one step further, the
it may prove too simple and will have additional compo-authors predicted that since OFQ/N can inhibit both
nents added to it in the future.primary and secondary cells, OFQ/N may produce an
The mysteries of the orphan opioid receptor and itsopioid-like increase in analgesia if the animal were in
ligand are far from over. Supraspinal pain modulationthe right behavioral state. They tested this idea using a
is but one of many proposed functions of this receptor.morphine withdrawal model. They pretreated rats with
In the spinal cord, OFQ/N is directly analgesic and pro-morphine, which caused analgesia. They then injected
duces an additive analgesic effect when combined withthe animals with the opioid receptor antagonist nalox-
morphine. The orphan opioid receptor is also found inone, which induced acute withdrawal and hyperalgesia.
a number of other brain regions outside the brainstem,Injection of OFQ/N into the NRM reversed the hyperalge-
including the hippocampus, where it has been sug-sia. Hence, in an animal experiencing opioid-induced
gested to play a role in modulating synaptic plasticityanalgesia OFQ/N increased pain sensitivity, but in an ani-
and memory formation. Finally, almost nothing is knownmal experiencing opioid withdrawal OFQ/N decreased
about the conditions under which the endogenous pep-pain sensitivity. OFQ/N can have bidirectional effects,
tide is released. Researchers are anxiously awaiting thedepending on the state of the animal.
development of selective antagonists and nonpeptideThe results of Pan et al. (2000) provide an interesting
agonists for this receptor. Such pharmacological re-model for supraspinal pain modulation. Primary and sec-
agents will certainly provide new insights into its func-ondary neurons in the NRM have functionally opposing
tion and may have potential medical applications for theactions on pain. OFQ/N's inhibitory effect on both of
control of pain. There is little doubt that OFQ/N and itsthese cell types may explain why it has no effect on
receptor will continue to surprise us for some time topain sensitivity when administered alone. Presumably,
come.pain sensitivity is regulated by the relative activity of
these two opposing cells. OFQ/N inhibits both cell types
James M. Brundegebut does not affect the balance of activity between these
Vollum Institutetwo cell types, and thus does not alter pain sensitivity
Oregon Health Sciences Universitywhen administered alone. m opioid receptors produce
Portland, Oregon 97201analgesia by directly inhibiting secondary cells, and indi-
rectly exciting primary cells, thus shifting the balance
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OFQ/N thus restores the balance of activity of primary rosci. 21, 215±221.
and secondary cells and reverses the effects of opioids, Fields, H.L. (2000). Prog. Brain Res. 122, 245±253.
regardless of whether those effects are analgesic or Heinricher, M.M., McGaraughty, S., and Grandy, D.K. (1997). J. Neu-
hyperalgesic. This model is intriguing and fits nicely with rophysiol. 78, 3351±3358.
the data. It is also in full accordance with the prior results Henderson, G., and McKnight, A.T. (1997). Trends Pharmacol. Sci.
18, 293±300.of Heinricher et al. (1997), which showed that OFQ/N
Meunier, J.C. (1997). Eur. J. Pharmacol. 340, 1±15.inhibited all of the identified cell types in this area of the
brainstem, and that m opioid receptor activation inhib- Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C.,
Alvinerie, P., Butour, J.L., Guillemot, J.C., Ferrara, P., and Monsarrat,ited on cells (analogous to secondary cells) but activated
B. (1995). Nature 377, 532±535.off cells (analogous to primary cells). Heinricher et al.
Mogil, J.S., Grisel, J.E., Reinscheid, R.K., Civelli, O., Belknap, J.K.,had also demonstrated that OFQ/N countered m recep-
and Grandy, D.K. (1996). Neuroscience 75, 333±337.tor±mediated activation of off (primary) cells, and this
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Tian, J.H., Xu, W., Fang, Y., Mogil, J.S., Grisel, J.E., Grandy, D.K., MuÈ ller cells contain receptors for most of the molecules
and Han, J.S. (1997). Br. J. Pharmacol. 120, 676±680. that have been shown to rescue photoreceptors; they
become stimulated, as indicated by the expression of
glial fibrillary acidic protein (GFAP), in response to a
variety of toxic stimuli, including retinal degeneration
(Ekstrom et al., 1998); transgenic experiments suggest
that loss of MuÈ ller cells leads to photoreceptor deathNeurotrophic Rescue of
(Dubois-Dauphin et al., 2000); and MuÈ ller cells, but notPhotoreceptors: Are MuÈ ller Cells
photoreceptors, are consistently activated by intraocu-
the Mediators of Survival? lar administration of BDNF, CNTF, and basic fibroblast
growth factor (FGF2), as measured by increased expres-
sion of the immediate-early protein c-fos and the phos-
phorylated form of the extracellular signal±regulated ki-Neuronal death in the retina has been studied not only
nase (pERK) (Wahlin et al., 2000).because of its own biological importance and its rele-
Although suggestive of a role for MuÈ ller cells in pro-vance to clinical disease, but also because retinal apo-
tecting photoreceptor cells from apoptosis, all of theptosis serves as a model system for death elsewhere
data just cited is itself indirect and fails to provide muchin the central nervous system (Nickells and Zack, 1996).
insight as to the mechanism by which MuÈ ller cells mightNeurodegenerative retinal diseases in which apoptosis
rescue photoreceptors. Harada et al. (2000), in this issuehas been implicated include photoreceptor degenera-
of Neuron, present new information that provides moretions such as retinitis pigmentosa and age-related de-
direct support for the MuÈ ller cell hypothesis and sug-generation, retinal ganglion cell diseases such as glau-
gests involvement of the low-affinity p75NTR neurotrophincoma and other optic neuropathies, and more panretinal
receptor in photoreceptor death in the adult retina. (Pre-diseases like diabetic retinopathy. In an effort to develop
vious work had already implicated p75NTR in cell deathnovel treatment approaches for these diseases, various
during retinal development [Casademunt et al., 1999].)anti-apoptotic strategies have been explored. Trans-
Using the phototoxicity model of retinal degeneration,genically engineered overexpression of bcl-2 in retinal
in which high-intensity and/or prolonged light exposureganglion cells leads to an inhibition of developmental
leads to photoreceptor cell loss, they show that degen-apoptosis and relative resistance of ganglion cells to
eration is associated with an increase in MuÈ ller celltoxic insults such as optic nerve axotomy. Although
expression of p75NTR and TrkC, and induction of TrkCmore controversial, some results suggest that bcl-2
expression by photoreceptor cells. Administration of ex-overexpression can also protect photoreceptors from
ogenous NT-3, which is photoreceptor cell protective,damage (Chen et al., 1996). Perhaps more promising
increased MuÈ ller cell production of FGF2, while NGFfrom a clinical point of view, neurotrophic factors, which
decreased its production. Functionally, they demon-inhibit neuronal apoptosis in a wide variety of systems,
strate that presumptive antibody-mediated blockade ofinhibit ganglion and photoreceptor cell death both in
p75NTR signaling prolongs photoreceptor survival. Mostvitro and in vivo (Steinberg, 1994; LaVail et al., 1998).
significantly, they show that in p75NTR null mice there isThe mechanism by which neurotrophic factors protect
a decrease in photoreceptor injury following light expo-photoreceptor cells from degeneration is unclear. Con-
sure. Putting this all together, the authors suggest atrol of neuronal survival by neurotrophins is generally
model in which there is a fine balance between pro- andmediated by two types of receptors: the Trk family of
antiapoptotic forces: MuÈ ller cells, acting in response tohigh-affinity tyrosine kinase receptors (TrkA, B, and C),
exogenous NT-3 or NGF via TrkC or p75NTR receptors,which usually transmit a prosurvival signal, and the neu-
respectively, increase or decrease their production ofrotrophin receptor p75NTR, which transmits an anti-sur-
the photoreceptor survival factor FGF2, which in turnvival signal (Casaccia-Bonnefil, 1999). A paradox in the
results in either the protection of photoreceptor cells orphotoreceptor field is that although brain-derived neuro-
increased apoptosis. In addition, since light-damagedtrophic factor (BDNF) and ciliary neurotrophic factor
photoreceptors express TrkC, NT-3 may also act directly(CNTF) have been consistently reported as neuroprotec-
upon injured photoreceptors. Interestingly, a similartive for rod photoreceptor cells, thus suggesting that
glial±neuronal interaction model has been proposed forthe corresponding receptors, TrkB and CNTFRa, are
the mechanism by which BDNF promotes retinal bipolarexpressed by these cells, most studies have thus far
cell survival in vitro (Wexler et al., 1998).failed to find evidence that mammalian rods express
An important innovation in the work by Harada et al.either TrkB or CNTFRa (Ugolini et al., 1995; Kirsch et al.,
is the use of laser capture microdissection (LCM) for the1997). As a result, it has been proposed that neurotophic
study of gene expression in subtypes of retinal cells.rescue of photoreceptors may be indirect, mediated by
Using LCM in conjunction with RT±PCR, they succeedinteraction of the neurotrophic factor with a nonphotore-
in measuring gene expression differences between pho-ceptor cell type that in turn releases a secondary factor,
toreceptors and inner nuclear layer cells. Although notor perhaps by a cell contact±mediated mechanism. Sev-
fully exploited in this study, LCM has the potential toeral lines of evidence suggest that the MuÈ ller cell may be
allow study of complex patterns of gene expressionan important player in this indirect rescue mechanism.
between neighboring and interacting cell populations.MuÈ ller cells are the predominant glial element in the
In a recent study, LCM was combined with cDNA mi-retina, and they carry out many of the functions provided
croarray analysis to compare the in vivo gene expressionby astrocytes, oligodendrocytes, and ependymal cells
elsewhere in the CNS (Newman and Richenbach, 1996). profiles of large and small dorsal root ganglia neurons
